InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the complete record of transactions filed by Schwartz Phillip, Président de la R&D. Officer active across 1 company, notably Entera Bio Ltd.. Aggregated, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €22k. History available since 20 January 2022. The latest transaction was filed on 20 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Phillip Schwartz is the President of R&D at Entera Bio Ltd. He oversees the company's research and development initiatives focused on innovation in the biotechnology field. His technical expertise is crucial for developing new therapies and supporting Entera Bio's mission.